Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John A. Orwin currently holds 12,000 shares of Travere Therapeutics, Inc. (TVTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John A. Orwin has been a net seller of TVTX stock. They have purchased $298.4K and sold $8.6M worth of shares.
John A. Orwin's most recent insider trade was on May 19, 2026, when they sold 12,000 shares at $0.00 per share.
John A. Orwin serves as Executive at Travere Therapeutics, Inc. (TVTX). They have executed 106 insider transactions totaling $8.9M over their tenure at the company.
John A. Orwin holds the position of Executive at Travere Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 16 years and currently hold a stake valued at $0.
John A. Orwin has shown a selling trading pattern, with $298.4K in total purchases and $8.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John A. Orwin was on Dec 14, 2023, when they sold $6.6M worth of SGEN shares. This transaction involved 29,003 shares at $229.00 per share.
John A. Orwin currently owns 12,000 shares of Travere Therapeutics, Inc. (TVTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John A. Orwin's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John A. Orwin has 106 Form 4 filings on record as an insider at Travere Therapeutics, Inc..
Set alerts for John A. Orwin and 40,000+ other insiders.